RxRevu

HEALTH TECHNOLOGY

Medical Home Network | January 12, 2022

Medical Home Network (MHN) is helping healthcare providers have more informed conversations with patients by enabling easy access to patient data in one place. With a timely and comprehensive view of patient information, providers can make more informed decisions and ultimately deliver better care. MHN is integrating patient data across different electronic medical record systems (EMRs) for 13 providers and more than 160,000 Medicaid safety net patients, making data accessible to pr...

Bio Products Laboratory | May 29, 2020

Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies with US headquarters in Durham, North Carolina, and worldwide headquarters and manufacturing facilities in Elstree, UK, today announced the US launch of ALBUMINEX 5% (human albumin) solution for injection and ALBUMINEX 25% (human albumin) solution for injection, with supply immediately available. ALBUMINEX 5% and ALBUMINEX 25% are approved by the US Food and Drug Administration for the treatment of hypovole...

FUTURE OF HEALTHCARE

House Rx | March 15, 2022

House Rx, a health technology platform focused on improving affordability and patient access to specialty medications, announced it has secured $25 million in Series A financing led by Bessemer Venture Partners, bringing total funding to $30 million. House Rx's technology platform and pharmacy service enable specialty practices to offer medically-integrated dispensing, which means patients can receive both their physician and pharmacy care from one team, collaborating on a unifi...

HEALTH TECHNOLOGY

NVIDIA | July 07, 2021

NVIDIA today officially launched Cambridge-1, the United Kingdom’s most powerful supercomputer, which will enable top scientists and healthcare experts to use the powerful combination of AI and simulation to accelerate the digital biology revolution and bolster the country’s world-leading life sciences industry. Dedicated to advancing healthcare, Cambridge-1 represents a $100 million investment by NVIDIA. Its first projects with AstraZeneca, GSK, Guy’s and ...